[1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
A Standard patent application filed on 27 December 2005 credited to Tsuhako, Amy Lew ; Le, Donna ; Co, Erick Wang ; Bussenius, Joerg ; Nuss, John ; Wang, Yong ; Bannen, Lynn Canne ; Kim, Moon Hwan ; Klein, Rhett Ronald ; Xu, Wei ; Rice, Ken

Details

Application number :

2005322085  

Application type :

Standard  

Application status :

ACCEPTED  

Under opposition :

No  

Proceeding type :

 

Invention title :

[1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases  

Inventor :

Tsuhako, Amy Lew ; Le, Donna ; Co, Erick Wang ; Bussenius, Joerg ; Nuss, John ; Wang, Yong ; Bannen, Lynn Canne ; Kim, Moon Hwan ; Klein, Rhett Ronald ; Xu, Wei ; Rice, Ken  

Agent name :

Davies Collison Cave  

Address for service :

1 Nicholson Street Melbourne VIC 3000 Australia  

Filing date :

27 December 2005  

Associated companies :

 

Applicant name :

Exelixis, Inc.  

Applicant address :

170 Harbor Way P.O. Box 511 South San Francisco CA 94083-0511 United States of America  

Old name :

 

Original Source :

Go